A single amino acid substitution of the human immunodeficiency virus type 1 capsid protein affects viral sensitivity to TRIM5α

Retrovirology

Volumn 7, Issue , 2010, Pages

  Kuroishi, Ayumu ^a   Bozek, Katarzyna ^b   Shioda, Tatsuo ^a   Nakayama, Emi E ^a  

^a OSAKA UNIVERSITY   (Japan)

^b MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; GLUTAMIC ACID; GLYCINE; TRIPARTITE MOTIF PROTEIN 5; CARRIER PROTEIN; GAG PROTEIN; P24 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; PROTEIN; TRIM5 PROTEIN, HUMAN; TRIM5(ALPHA) PROTEIN, RHESUS MONKEY;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MOLECULAR CLONING; MUTATION; NONHUMAN; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; STATISTICAL MODEL; VIRUS REPLICATION; VIRUS RESISTANCE; ANIMAL; CELL LINE; CHEMICAL STRUCTURE; CULTURE TECHNIQUE; GENETICS; IMMUNOLOGY; MACACA; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; T LYMPHOCYTE; VIROLOGY;

CERCOPITHECIDAE; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA FASCICULARIS; MIRIDAE; PAN;

AMINO ACID SUBSTITUTION; ANIMALS; CARRIER PROTEINS; CELL CULTURE TECHNIQUES; CELL LINE; DNA MUTATIONAL ANALYSIS; HIV CORE PROTEIN P24; HIV-1; HUMANS; MACACA FASCICULARIS; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEINS; T-LYMPHOCYTES;

EID: 77954278670     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-58     Document Type: Article

References (31)

1. Shibata R, Sakai H, Kawamura M, Tokunaga K, Adachi A. Early replication block of human immunodeficiency virus type 1 in monkey cells. J Gen Virol 1995, 76(Pt 11):2723-2730. 10.1099/0022-1317-76-11-2723, 7595379.
2. Himathongkham S, Luciw PA. Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology 1996, 219:485-488. 10.1006/viro.1996.0276, 8638416.
3. Hofmann W, Schubert D, LaBonte J, Munson L, Gibson S, Scammell J, Ferrigno P, Sodroski J. Species-specific, postentry barriers to primate immunodeficiency virus infection. J Virol 1999, 73:10020-10028. 113053, 10559316.
4. Shibata R, Kawamura M, Sakai H, Hayami M, Ishimoto A, Adachi A. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J Virol 1991, 65:3514-3520. 241342, 2041078.
5. Kamada K, Igarashi T, Martin MA, Khamsri B, Hatcho K, Yamashita T, Fujita M, Uchiyama T, Adachi A. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc Natl Acad Sci USA 2006, 103:16959-16964. 10.1073/pnas.0608289103, 1622925, 17065315.
6. Goila-Gaur R, Strebel K. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 2008, 5:51. 10.1186/1742-4690-5-51, 2443170, 18577210.
7. Berthoux L, Sebastian S, Sokolskaja E, Luban J. Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA. J Virol 2004, 78:11739-11750. 10.1128/JVI.78.21.11739-11750.2004, 523245, 15479815.
8. Kootstra NA, Munk C, Tonnu N, Landau NR, Verma IM. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc Natl Acad Sci USA 2003, 100:1298-1303. 10.1073/pnas.0337541100, 298767, 12547912.
9. Nakayama EE, Shingai Y, Kono K, Shioda T. TRIM5alpha-independent anti-human immunodeficiency virus type 1 activity mediated by cyclophilin A in Old World monkey cells. Virology 2008, 375:514-520. 10.1016/j.virol.2008.02.028, 18367226.
10. Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, Johnson MC, Stephens EB, Guatelli J. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3:245-252. 10.1016/j.chom.2008.03.001, 2474773, 18342597.
11. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430. 10.1038/nature06553, 18200009.
12. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853. 10.1038/nature02343, 14985764.
13. Luban J. Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection. J Virol 2007, 81:1054-1061. 10.1128/JVI.01519-06, 1797489, 16956947.
14. Towers GJ. The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology 2007, 4:40. 10.1186/1742-4690-4-40, 1906832, 17565686.
15. Hatziioannou T, Ambrose Z, Chung NP, Piatak M, Yuan F, Trubey CM, Coalter V, Kiser R, Schneider D, Smedley J, Pung R, Gathuka M, Estes JD, Veazey RS, KewalRamani VN, Lifson JD, Bieniasz PD. A macaque model of HIV-1 infection. Proc Natl Acad Sci USA 2009, 106:4425-4429. 10.1073/pnas.0812587106, 2657417, 19255423.
16. Kamada K, Yamashita T, Hatcho K, Adachi A, Nomaguchi M. Evasion from CypA- and APOBEC-mediated restrictions is insufficient for HIV-1 to efficiently grow in simian cells. Microbes Infect 2009, 11:164-171. 10.1016/j.micinf.2008.11.002, 19056509.
17. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S, Guffanti A, Minucci S, Pelicci PG, Ballabio A. The tripartite motif family identifies cell compartments. EMBO J 2001, 20:2140-2151. 10.1093/emboj/20.9.2140, 125245, 11331580.
18. Nakayama EE, Miyoshi H, Nagai Y, Shioda T. A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection. J Virol 2005, 79:8870-8877. 10.1128/JVI.79.14.8870-8877.2005, 1168783, 15994780.
19. Ohkura S, Yap MW, Sheldon T, Stoye JP. All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction. J Virol 2006, 80:8554-8565. 10.1128/JVI.00688-06, 1563890, 16912305.
20. Li Y, Li X, Stremlau M, Lee M, Sodroski J. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection. J Virol 2006, 80:6738-6744. 10.1128/JVI.00270-06, 1489046, 16809279.
21. Sawyer SL, Wu LI, Emerman M, Malik HS. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci USA 2005, 102:2832-2837. 10.1073/pnas.0409853102, 549489, 15689398.
22. Perez-Caballero D, Hatziioannou T, Yang A, Cowan S, Bieniasz PD. Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity. J Virol 2005, 79:8969-8978. 10.1128/JVI.79.14.8969-8978.2005, 1168745, 15994791.
23. Song H, Nakayama EE, Yokoyama M, Sato H, Levy JA, Shioda T. A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas. J Virol 2007, 81:7280-7285. 10.1128/JVI.00406-07, 1933286, 17475650.
24. Kuroishi A, Saito A, Shingai Y, Shioda T, Nomaguchi M, Adachi A, Akari H, Nakayama EE. Modification of a loop sequence between alpha-helices 6 and 7 of virus capsid (CA) protein in a human immunodeficiency virus type 1 (HIV-1) derivative that has simian immunodeficiency virus (SIVmac239) vif and CA alpha-helices 4 and 5 loop improves replication in cynomolgus monkey cells. Retrovirology 2009, 6:70. 10.1186/1742-4690-6-70, 2731049, 19650891.
25. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986, 59:284-291. 253077, 3016298.
26. Miyoshi H, Takahashi M, Gage FH, Verma IM. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA 1997, 94:10319-10323. 10.1073/pnas.94.19.10319, 23360, 9294208.
27. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM. Development of a self-inactivating lentivirus vector. J Virol 1998, 72:8150-8157. 110156, 9733856.
28. Kono K, Song H, Shingai Y, Shioda T, Nakayama EE. Comparison of anti-viral activity of rhesus monkey and cynomolgus monkey TRIM5alphas against human immunodeficiency virus type 2 infection. Virology 2008, 373:447-456. 10.1016/j.virol.2007.12.022, 18201746.
29. Tang C, Ndassa Y, Summers MF. Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein. Nat Struct Biol 2002, 9:537-543.
30. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY, Pieper U, Sali A. Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci 2007, Chapter 2. Unit 2 9.
31. Maegawa H, Nakayama EE, Kuroishi A, Shioda T. Silencing of tripartite motif protein (TRIM) 5alpha mediated anti-HIV-1 activity by truncated mutant of TRIM5alpha. J Virol Methods 2008, 151:249-256. 10.1016/j.jviromet.2008.04.012, 18524394.